US Stem Cell Inc (USRM)

[Dragon Lady]

About $1,275 total dollars traded today, wow.

And last trade was posted at about 2:56 PM Eastern, meaning it flat lined out w/o a single trade for more than 1 hour, despite the bid being so low at .0215 Seems like one large or even medium sized seller in here now and this is going under 2 cents a share IMO. It's totally broken down below the 200 DMA and the 50 DMA is now crossing under the 200 DMA.

Don't know how they're gonna raise any big financing on numbers and volume like that? Market cap is now back at just $11 million, pretty close to their outstanding major debts again.

Seems like all the PR and good news just isn't moving the needle at this point?

Not sure anymore IMO if they're now supposed to be some kind of off-shore, 2nd/3rd world "medical tourism" company offering unproven "cell treatments and therapies" for cash in these sort of odd-ball partnership deals? Or are they even still attempting to be a real "heart research" and FDA type trial and medical product research company anymore or what? I mean, the name still says BioHEART, but that sure doesn't seem to be the focus or goal anymore that I can see?

It's very confusing IMHO? I'm not "getting it" or the long term plans anymore? It used to be real clear- "heart" related research trials to get an FDA approved product to the finish line- I just don't see that anymore, per my 2 cents. Not when the R&D budget is running $5K a month but 2 people just got a sum total $800K in just "bonuses" ($800K/12 = $66K a month) and then a few pages later in that same 10-Q filing, it says all major trials are "on hold" for "lack of funding" and they finished the qtr near cash broke again??

I think Pyrrhonian pointed out and made that same point pretty well IMO